Geron | GERN - Les Charges D'Exploitation

Prix De L'Action
1.50
Variation Quotidienne
0 0%
Mensuellement
-4.46%
Annuel
5.63%
Q2 Prévisions
1.47




Les Charges D'Exploitation Changement Date
Amgen USD 5.9B 773M 2025-12
Bio Techne USD 241.42M 2.52M 2025-12
Cassava Sciences USD 13.55M 1.69M 2025-12
Cytokinetics USD 196.12M 27.43M 2025-12
Esperion Therapeutics USD 83.21M 14.06M 2025-12
Exelixis USD 362.75M 21.35M 2025-12
Genmab DKK 798M 235M 2025-12
Geron USD 58.8M 2.31M 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
Incyte USD 1.12B 3.53B 2025-12
MacroGenics USD 53.32M 13.68M 2025-12
Novartis USD 9.8B 61M 2025-12
Novavax USD 126.2M 23.62M 2025-12